Schonfeld Strategic Advisors LLC Unity Biotechnology, Inc. Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.29 $21,672 - $49,923	-38,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.72 - $1.86 $27,864 - $71,982	38,700 New	38,700 $43,000
Q4 2021 Feb 14, 2022	SELL	$1.3 - $3.17 $18,460 - $45,014	-14,200 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$2.91 - $4.5 $10,767 - $16,650	-3,700 Reduced 20.67%	14,200 $43,000
Q2 2021 Aug 16, 2021	BUY	$4.15 - $6.3 $74,285 - $112,770	17,900 New	17,900 $83,000
Q4 2020 Feb 16, 2021	SELL	$3.42 - $6.36 $114,912 - $213,696	-33,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $98,784 - $417,648	33,600 New	33,600 $0

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14.5M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.